IGM Biosciences, Inc. (IGMS)
Au 14, 2025 - IGMS was delisted (reason: acquired by Concentra Biosciences)
1.270
-0.030 (-2.31%)
Inactive · Last trade price on Aug 13, 2025

IGM Biosciences Statistics

Total Valuation

Market Cap n/a
Enterprise Value n/a

Important Dates

The last earnings date was Thursday, July 31, 2025, after market close.

Earnings Date Jul 31, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +1.64%
Shares Change (QoQ) +0.96%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 36.59M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 4.09
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 17.66

Current Ratio 17.66
Quick Ratio 17.29
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -47.82% and return on invested capital (ROIC) is 4.88%.

Return on Equity (ROE) -47.82%
Return on Assets (ROA) 2.89%
Return on Invested Capital (ROIC) 4.88%
Return on Capital Employed (ROCE) 10.17%
Revenue Per Employee $9.07M
Profits Per Employee -$3.34M
Employee Count149
Asset Turnover 0.65
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -85.70% in the last 52 weeks. The beta is 0.59, so IGM Biosciences's price volatility has been lower than the market average.

Beta (5Y) 0.59
52-Week Price Change -85.70%
50-Day Moving Average 1.27
200-Day Moving Average 3.58
Relative Strength Index (RSI) 47.94
Average Volume (20 Days) 480,746

Short Selling Information

The latest short interest is 452,126, so 0.75% of the outstanding shares have been sold short.

Short Interest 452,126
Short Previous Month 404,560
Short % of Shares Out 0.75%
Short % of Float 1.86%
Short Ratio (days to cover) 0.69

Income Statement

In the last 12 months, IGM Biosciences had revenue of $145.05 million and -$53.39 million in losses. Loss per share was -$0.88.

Revenue145.05M
Gross Profit -5.49M
Operating Income 10.26M
Pretax Income -53.39M
Net Income -53.39M
EBITDA 17.63M
EBIT 10.26M
Loss Per Share -$0.88
Full Income Statement

Balance Sheet

The company has $104.31 million in cash and n/a in debt, giving a net cash position of $104.31 million.

Cash & Cash Equivalents 104.31M
Total Debt n/a
Net Cash 104.31M
Net Cash Per Share n/a
Equity (Book Value) 100.93M
Book Value Per Share 1.68
Working Capital 100.93M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$156.51 million and capital expenditures -$2.19 million, giving a free cash flow of -$158.70 million.

Operating Cash Flow -156.51M
Capital Expenditures -2.19M
Free Cash Flow -158.70M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is -3.79%, with operating and profit margins of 7.07% and -36.80%.

Gross Margin -3.79%
Operating Margin 7.07%
Pretax Margin -36.80%
Profit Margin -36.80%
EBITDA Margin 12.16%
EBIT Margin 7.07%
FCF Margin n/a

Dividends & Yields

IGM Biosciences does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.64%
Shareholder Yield -1.64%
Earnings Yield n/a
FCF Yield n/a

Analyst Forecast

The average price target for IGM Biosciences is $6.00, which is 372.44% higher than the current price. The consensus rating is "Hold".

Price Target $6.00
Price Target Difference 372.44%
Analyst Consensus Hold
Analyst Count 8
Revenue Growth Forecast (5Y) 2.97%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

IGM Biosciences has an Altman Z-Score of 28.83 and a Piotroski F-Score of 4.

Altman Z-Score 28.83
Piotroski F-Score 4